Press releases Year None202220212020201920182017201620152014 Aug 01, 2022 Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus Jul 25, 2022 Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update Jul 18, 2022 Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update May 18, 2022 Otonomy to Participate in the H.C. Wainwright Global Investment Conference May 12, 2022 Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual Meeting May 09, 2022 Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate Update May 02, 2022 Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate Update Apr 20, 2022 Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss Mar 15, 2022 Otonomy to Host Virtual Investor R&D Event on March 22, 2022 Feb 28, 2022 Otonomy Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update Pagination Current page 1 Page 2 Next page next › Last page last »
